Chemical Structure 29.1
Gabapentin
Chemical Structure 29.2
Phenytoin
Chemical Structure 29.3
Carbamazepine
Chemical Structure 29.4
Lamotrigine
Chemical Structure 29.5
Levetiracetam
Chemical Structure 29.6
Topiramate
Chemical Structure 29.7
Ethosuximide
References
1.
Sirven JI, Noe K, Hoerth M, Drazkowski J. Antieplileptic drugs 2012: recent advances and trends. Mayo Clin Proc. 2012;87(9):879–89.PubMedCentralPubMed
2.
Ochoa JG, Benbadi SR, Riche W, Passaro EA, Talavera F. Antiepileptic drugs. Medscape Reference © 2011 WebMD, LLC [updated 25 Oct 2012]
3.
Perucca E. An introduction to antiepileptic drugs. Epilepsia. 2005;46(Suppl 4):31-37
4.
White HS, Smith MD, Wilcox KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol. 2007;81:85–110.PubMed
5.
Woelfel JA, Cupp M. Comparison of antiepileptic drugs. Pharmacist’s Letter/Prescriber’s Letter, Detail-Document #250707. 2009;25#250707:1–24
6.
Brunton LL, Chabner B, Knollman BC. 12e. Section 2. Neuropharmacology. Chapter 21. Pharmacotherapy of the epilepsies. In: Goodman and Gilman’s pharmacological basis of therapeutics. New York: McGraw-Hill; 2011.
7.
Perucca P, Mula M. Antiepileptic drug effects on mood and behavior: molecular targets. Epilepsy Behav. 2012. Available from: http://dx.doi.org/10.1016/j.yebeh.2012.09.018.
8.
Hung C, Chen JW. Treatment of post-traumatic epilepsy. Curr Treat Options Neurol. 2012;14:293–306.PubMed
9.
Bialer M, White HS. Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9:68–82.PubMed
10.
Cavazos JE, Benbadis SR, Diaz-Arrastia R, Spitz M, Talavera F. Epilepsy and seizures. Medscape Reference ©2011WebMD, LLC [updated 25 Oct 2012]
11.
Wang SP, Mintzer S, Skidmore CT, Zhan T, Stuckert E, Nei M, et al. Seizure recurrence and remission after switching antiepileptic drugs. Epilepsia. 2013;54:187–93.PubMedCentralPubMed
12.
Löscher W, Schmidt D. Perampanel – new promise for refractory epilepsy? Nat Rev Neurol. 2012;13:1–2.
13.
Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49 Suppl 9:63–73.PubMed
14.
Kleckner NW, Glazewski JC, Chen CC, Moscrip TD. Subtype-selective antagonism of N-Methyl-D-Aspartate receptors by felbamate: insights into the mechanism of action. J Pharmacol Exp Ther. 1999;289(2):886–94.PubMed
15.
Ohno Y, Sofue N, Imaoku T, Morishita E, Kumafuji K, Sasa M, et al. Serotonergic modulation of absence-like seizures in groggy rats: a novel rat model of absence epilepsy. J Pharmacol Sci. 2012;114:99–105.
16.
Ezogabine FE. A new angle on potassium gates. Epilepsy Curr. 2011;11(3):75–8.
17.
Son YJ, Scranton TW, Sunderland WJ, Baek SJ, Miner JH, Sanes JR, et al. The synaptic vesicle protein SV2 is complexed with an α5-containing laminin on the nerve terminal surface. J Biol Chem. 2000;275(1):451–60.PubMed
Related posts:
Full access? Get Clinical Tree
